Thermo Fisher Scientific Inc. Share Price
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
529.00 USD | -1.01% | +1.35% | -0.39% |
Capitalization | 204B 194B 181B 161B 288B 17,316B 316B 2,252B 835B 7,101B 768B 751B 30,564B | P/E ratio 2024 * |
32.8x | P/E ratio 2025 * | 29.3x |
---|---|---|---|---|---|
Enterprise value | 230B 219B 204B 182B 324B 19,504B 356B 2,537B 940B 7,998B 865B 846B 34,424B | EV / Sales 2024 * |
5.38x | EV / Sales 2025 * | 4.98x |
Free-Float |
86.06% | Yield 2024 * |
0.28% | Yield 2025 * | 0.3% |
Last Transcript: Thermo Fisher Scientific Inc.
1 day | +0.27% | ||
1 week | +2.66% | ||
Current month | +1.11% | ||
1 month | -3.59% | ||
3 months | -12.48% | ||
6 months | -5.99% | ||
Current year | +0.89% |
Director | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 14/10/2009 |
Director of Finance/CFO | 57 | 31/07/2015 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2023 |
Manager | Title | Age | Since |
---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 66 | 08/11/2006 |
Marc Casper
CHM | Chairman | 56 | 25/02/2020 |
Tyler Jacks
BRD | Director/Board Member | 63 | 25/05/2009 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.69% | 2 M€ | -25.75% | ||
7.43% | 20 M€ | +16.48% | - | |
5.37% | 2 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.17% | +2.66% | +8.11% | -13.94% | 204B | ||
+1.88% | +2.21% | +76.52% | +70.02% | 193B | ||
-0.80% | +0.12% | +7.65% | -22.09% | 174B | ||
+0.90% | +0.40% | +66.35% | +123.86% | 133B | ||
+0.08% | +1.65% | -1.11% | -18.73% | 60.83B | ||
-0.44% | -2.63% | -10.53% | -26.47% | 43.28B | ||
+4.64% | +1.48% | +5.72% | -34.67% | 41.4B | ||
+1.20% | +1.78% | +9.09% | -7.18% | 39.72B | ||
+0.59% | +0.04% | +19.69% | - | 37.72B | ||
-1.11% | -2.29% | +50.81% | -6.41% | 36.23B | ||
Average | +0.72% | +0.74% | +23.23% | +7.16% | 96.39B | |
Weighted average by Cap. | +0.63% | +1.29% | +30.36% | +20.62% |
2024 * | 2025 * | |
---|---|---|
Net sales | 42.81B 40.73B 37.94B 33.82B 60.23B 3,627B 66.12B 472B 175B 1,487B 161B 157B 6,401B | 45.11B 42.91B 39.97B 35.63B 63.46B 3,821B 69.67B 497B 184B 1,567B 169B 166B 6,745B |
Net income | 6.14B 5.84B 5.44B 4.85B 8.64B 520B 9.49B 67.68B 25.09B 213B 23.08B 22.56B 918B | 6.94B 6.6B 6.15B 5.48B 9.77B 588B 10.72B 76.49B 28.36B 241B 26.09B 25.5B 1,038B |
Net Debt | 25.82B 24.56B 22.88B 20.39B 36.32B 2,187B 39.88B 284B 105B 897B 97.02B 94.85B 3,861B | 20.28B 19.29B 17.97B 16.02B 28.53B 1,718B 31.32B 223B 82.85B 705B 76.21B 74.5B 3,033B |
Date | Price | Change | Volume |
---|---|---|---|
04/12/24 | 528.65 $ | -1.08% | 1,353,462 |
03/12/24 | 534.42 $ | +0.84% | 2,665,203 |
02/12/24 | 529.95 $ | +0.06% | 2,558,569 |
29/11/24 | 529.63 $ | +1.53% | 2,108,339 |
27/11/24 | 521.66 $ | +1.69% | 2,914,199 |
Delayed Quote Nyse, December 04, 2024 at 04:31 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
MarketScreener is also available in this country: United States.
Switch edition